← ANALYSTS · TIPRANKS
Matt Phipps · William Blair
Hits
48%
216 of 450 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+4.8%
Over a year after the rating, TipRanks’ measure
Our companies rated now
23
Buy / hold / sell: 18 / 5 / 0
Upside of the analyst’s targets
—
Average over 0 current targets, to the last price
The market’s answer to the ratings
−0.5%
Day-0 move against SPY in the rating’s direction, average over 1 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 12on TipRanks 14:10 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Hold | — | — | −2.5%next day −1.6% | ↗ |
| Oct 8on TipRanks Oct 12 09:45 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Hold | — | — | +0.2%next day −1.4% · 5 days +1.9% | ↗ |
| Oct 5on TipRanks 06:25 | GMABGenmab · $22.3B | Reiterated | Buy | — | — | +10.1%next day −2.3% · 5 days −3.3% | ↗ |
| Oct 2on TipRanks 09:55 | CGEMIWMCullinan Management · $901M | Reiterated | Buy | — | — | +6.0%next day +2.7% · 5 days −1.0% | ↗ |
| Sep 30on TipRanks 14:15 | JBIOIWMJade Biosciences · $855M | Reiterated | Buy | — | — | −0.7%next day −2.2% · 5 days −3.9% | ↗ |
| Sep 28on TipRanks 11:06 | ABBVSPYAbbVie · $501B | Reiterated | Buy | — | — | +1.5%next day −0.9% · 5 days −1.4% | ↗ |
| Sep 25on TipRanks 11:07 | AUTLAutolus Therapeutics · $474M | Reiterated | Buy | — | — | −3.4%next day +1.0% · 5 days −3.8% | ↗ |
| Sep 24on TipRanks 15:35 | CGEMIWMCullinan Management · $901M | Reiterated | Buy | — | — | −8.4%next day −4.6% · 5 days −5.5% | ↗ |
| Sep 24on TipRanks 08:45 | KYTXIWMKyverna Therapeutics, Inc. · $369M | Reiterated | Buy | — | — | −1.0%next day −3.1% · 5 days −6.3% | ↗ |
| Sep 22on TipRanks 15:07 | CMPXIWMCompass Therapeutics · $158M | Reiterated | Buy | — | — | −31.9%next day −4.9% · 5 days −10.1% | ↗ |
| Sep 22on TipRanks 11:16 | AMGNQQQSPYAmgen · $235B | Reiterated | Buy | — | — | +4.4%next day −0.3% · 5 days +4.5% | ↗ |
| Sep 18on TipRanks 04:35 | NAMSNewAmsterdam Pharma Company · $2.4B | Reiterated | Buy | — | — | +2.4%next day −1.2% · 5 days −0.9% | ↗ |
| Sep 15on TipRanks 16:20 | ZNTLIWMZentalis Pharmaceuticals · $212M | Initiated | Buy | — | — | −0.5%next day −1.8% · 5 days −9.5% | ↗ |
| Sep 9on TipRanks 05:30 | EVMNIWMEvommune, Inc. · $215M | Reiterated | Hold | — | — | −16.7%next day −2.0% · 5 days −12.5% | ↗ |
| Sep 8on TipRanks 17:15 | UPBIWMUpstream Bio, Inc. · $185M | Reiterated | Buy | — | — | −3.3%next day −2.9% · 5 days −9.5% | ↗ |
| Sep 3on TipRanks 09:55 | CLYMIWMClimb Bio · $627M | Reiterated | Buy | — | — | −4.1%next day +6.8% · 5 days −1.2% | ↗ |
| Sep 2on TipRanks 11:45 | ARGXArgenx Se · $51.7B | Reiterated | Buy | — | — | +2.2%next day −1.2% · 5 days −5.8% | ↗ |
| Aug 31on TipRanks 07:15 | TENXIWMTenax Therapeutics · $57M | Reiterated | Hold | — | — | −13.3%next day −1.5% · 5 days +7.8% | ↗ |
| Aug 19on TipRanks 14:45 | INCYSPYIncyte · $23.0B | Reiterated | Hold | — | — | +3.8%next day −0.1% · 5 days +0.1% | ↗ |
| Aug 14on TipRanks 04:05 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Hold | — | — | −1.1%next day +1.7% · 5 days +6.4% | ↗ |
| Aug 13on TipRanks 18:25 | JANXIWMJanux Therapeutics Inc · $1.1B | Reiterated | Buy | — | — | +0.9%next day +1.3% · 5 days +9.2% | ↗ |
| Aug 11on TipRanks 16:05 | ZURAIWMZura Bio · $423M | Reiterated | Buy | — | — | +3.7%next day −3.3% · 5 days +1.5% | ↗ |
| Aug 6on TipRanks 12:45 | INSMInsmed · $21.5B | Reiterated | Buy | — | — | +34.0%next day −1.7% · 5 days −5.9% | ↗ |
| Aug 6on TipRanks 09:15 | CNTXIWMContext Therapeutics · $22M | Reiterated | Buy | — | — | −27.1%next day −4.6% · 5 days −0.8% | ↗ |
| Aug 6on TipRanks 01:19 | XNCRIWMXencor · $1.8B | Reiterated | Buy | — | — | +1.0%next day +3.4% · 5 days +13.7% | ↗ |
| Aug 4on TipRanks 04:22 | KROSIWMKeros Therapeutics · $219M | Reiterated | Hold | — | — | −0.4%next day −2.3% · 5 days +3.9% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗